Amgen Inc. (AMGN) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Amgen Inc. (AMGN:NASDAQ), powered by AI.
- Current Price
- $347.84
- P/E Ratio
- 24.3
- Market Cap
- 187.1B
- Sector
- Healthcare
What is the Amgen Inc. stock price forecast?
Amgen Inc. is currently trading at $347.84. View real-time AI analysis on Alpha Lenz.
What is Amgen Inc. insider trading activity?
View the latest insider trading data for Amgen Inc. on Alpha Lenz.
What is Amgen Inc.'s P/E ratio?
Amgen Inc.'s P/E ratio is 24.3.
Amgen Inc.
NASDAQ · AMGN“Amgen Inc. trades at a P/E of 24.3 (fair value) with strong ROE of 106.1%. 3Y revenue CAGR of 11.8% highlights clear growth momentum.”
Ask for details →Company Overview
Amgen Inc. is a leading biotechnology company focused on the discovery, development, manufacturing, and marketing of human therapeutics. Established in 1980 and headquartered in Thousand Oaks, California, Amgen is recognized for pioneering biologic treatments and having a robust pipeline that targets critical areas like oncology, cardiovascular, and nephrology. The company has harnessed advanced technology platforms and deep scientific expertise to deliver innovative medicines such as Neulasta, Enbrel, and Prolia, which are significant players in the health care sector. Amgen serves markets globally, impacting the biotech industry by transforming the ways diseases are treated. Its investment in state-of-the-art manufacturing facilities and research makes it a significant entity in the pharmaceutical landscape, contributing to long-term health care solutions.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Amgen Inc. trades at a P/E of 24.3 (fair value) with strong ROE of 106.1%. 3Y revenue CAGR of 11.8% highlights clear growth momentum.”
Ask for details →Frequently Asked Questions
Amgen Inc. (ticker: AMGN) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - General). It has approximately 28,000 employees. Market cap is $187.1B.
The current price is $347.84 with a P/E ratio of 24.27x and P/B of 21.61x.
ROE is 106.10% and operating margin is 24.71%. Annual revenue is $36.8B.